Target intelligence / Profile preview

Calponin 2 pseudogene 3 (CNN2P3)

Target
CNN2P3
Molecular classification
Other (Pseudogene)
01

Overview

Calponin 2 pseudogene 3 (CNN2P3) is one of several pseudogenes of the functional calponin 2 gene (CNN2), which is located on chromosome 19p13.3 in humans and encodes a thin filament-associated protein involved in actin cytoskeleton regulation, particularly in smooth muscle contraction and cell adhesion[6][5][2]. CNN2P3 itself is a pseudogene, meaning it is a noncoding DNA sequence that resembles the functional CNN2 gene but contains mutations or alterations (such as stop codons, frameshifts, or missing regulatory sequences) that prevent it from being expressed as a functional protein[2][6]. Several pseudogenes of CNN2 have been identified in the human genome on chromosomes 1, 2, 3, 6, 9, 11, 13, 15, 16, 21 and 22[2][6]. There is currently no evidence that CNN2P3 is expressed or has a biological, pharmacological, or disease role. The functional, protein-coding gene is calponin 2 (CNN2), whereas CNN2P3 is a pseudogene. If a therapeutic or biological inquiry references CNN2P3, this is likely to be incorrect or irrelevant unless for purposes of studying pseudogene regulation or genomic mapping, not drug targeting. Pseudogenes may be incorrectly annotated as potential targets in some databases—careful verification is required. The canonical therapeutic target, if desired, would be "Calponin 2" (CNN2), not CNN2P3[5][6][2]. CNN2P3 is a nonfunctional pseudogene of the calponin 2 gene, has no known biological or clinical function, and is not a drug target[2][6][5]. The entry is best flagged as not a legitimate therapeutic or functional target.

Other names
CNN2P3calponin II pseudogene 3calponin 2 processed pseudogene 3pseudogene of CNN2 on chromosome 3
02

Mechanism of action

None

03

Biological functions

None (no known biological function; pseudogenes are by definition nonfunctional remnants of genes)
04

Disease associations

None (pseudogenes rarely, but not never, play roles in disease; no evidence for CNN2 pseudogenes in disease directly)

Beyond the preview

Go deeper on Calponin 2 pseudogene 3 (CNN2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calponin 2 pseudogene 3 (CNN2P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call